Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

Details for Australian Patent Application No. 2005209322 (hide)

Owner The Regents of the University of California

Inventors Parsons, C. Lowell

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005209322

PCT Pub. Number WO2005/072751

Priority 60/540,186 28.01.04 US

Filing date 27 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 19 May 2011

International Classifications

A61K 31/727 (2006.01)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/072751 Priority application(s): WO2005/072751

19 May 2011 Application Accepted

  Published as AU-B-2005209322

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209326-Solvent extraction process for separating cobalt and/or manganese from impurities in leach solutions

2005209321-Fluid delivery system and method